Nephrology
- What is the role for terlipressin in hepatorenal syndrome?
The drug is recommended as a first-line treatment of hepatorenal syndrome-related acute kidney injury, but it is associated with respiratory failure, especially in the setting of albumin administration, and certain comorbidities may increase the risk.
- The new GFR equations: How will eliminating the race coefficient affect Black patients?
The authors discuss the history of equations for the glomerular filtration rate and potential clinical consequences of the new equations.
- A useful gap
A very low anion gap can suggest a laboratory measurement error or provide a clue to clinically important protein abnormalities or ingestions that warrant specific investigation.
- Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?
These conditions often co-exist and can have complex interactions. The progression of kidney disease increases the risk of major adverse cardiovascular events.
- Evaluating a low anion gap: A practical approach
In teaching and in practice, little attention is given to a low anion gap, an oversight that can result in a missed opportunity to diagnose acute or chronic disorders requiring treatment.
- When should pharmacologic therapies be used for uremic pericarditis?
If symptoms return or fail to improve with renal replacement therapy, drug therapy may be considered.
- Evaluating troponin elevation in patients with chronic kidney disease and suspected acute coronary syndrome
The authors examine challenges in diagnosing acute coronary syndrome in patients with chronic kidney disease and provide a diagnostic algorithm to risk-stratify these patients.